Placement to Raise $15m with Cornerstone Investment
by Leading USA Biotech Investor
• $15m Placement to fund further development of Actinogen Medical’s lead drug, Xanamem, with
cornerstone investment from leading USA biotech investor Biotechnology Value Fund, L.P. and certain
of its affiliates (BVF)
• Placement price of $0.05 per share represents an 13.4% premium to the 5-day VWAP
• BVF to become the largest shareholder following completion of the Placement with a 19.9% holding
• Investment from significant biotech investor provides validation of Xanamem’s innovative potential
in the treatment of Alzheimer’s disease and other conditions associated with cognitive impairment
• Placement coincides with positive outcome of XanADu Interim Analysis
• Share Purchase Plan at $0.05 per share to raise up to a further $2m, bringing the total capital raised
to a maximum of $17m
• Shareholder meeting to be held for approvals required under this Placement
• Investor conference call with key members of management and the Company’s Clinical Advisory Board
to take place on Wednesday 30th of May at 10:30am AEST
- Forums
- ASX - By Stock
- Ann: $15m Placement Completed-Including US Cornerstone Investor
Placement to Raise $15m with Cornerstone Investment by Leading...
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACW (ASX) to my watchlist
|
|||||
Last
7.4¢ |
Change
-0.007(8.64%) |
Mkt cap ! $200.3M |
Open | High | Low | Value | Volume |
8.0¢ | 8.0¢ | 7.2¢ | $548.8K | 7.212M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 377845 | 7.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.5¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 377845 | 0.074 |
2 | 286985 | 0.073 |
2 | 116109 | 0.072 |
4 | 152568 | 0.071 |
9 | 780796 | 0.070 |
Price($) | Vol. | No. |
---|---|---|
0.075 | 50000 | 1 |
0.076 | 64068 | 1 |
0.077 | 111062 | 2 |
0.078 | 243218 | 5 |
0.079 | 189896 | 3 |
Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
Featured News
ACW (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online